Open AccessHelicobacter pyloriand gastric cancer: current status of the Austrain Czech German gastric cancer prevention trial (PRISMA-Study)
Author(s) -
Stephan Miehlke,
Christian Kirsch,
B Dragosics,
Michael Gschwantler,
Georg Oberhuber,
David Antoš,
Petr Dítě,
Jürgen Läuter,
Joachim Labenz,
Andreas Leodolter,
Peter Malfertheiner,
Andreas Neubauer,
Gerhard Ehninger,
Manfred Stolte,
Ekkehard Bayerdörffer
Publication year - 2001
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v7.i2.243
Subject(s) - medicine , gastroenterology , helicobacter pylori , cancer , omeprazole , clarithromycin , gastritis , randomized controlled trial , intestinal metaplasia , dysplasia , atrophic gastritis
To test the hypothesis that Helicobacter pylori eradication alone can reduce the incidence of gastric cancer in a subgroup of individuals with an increased risk for this fatal disease.